Trade Summary

Yesterday, Klein Lawrence Otto, serving as CEO at Oruka Therapeutics, Inc. (ORKA), sold 1,729 shares at $41.30 per share, for a total transaction value of $71,408.00. Following this transaction, Klein Lawrence Otto now holds 927,309 shares of ORKA.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.